US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 2.898
  • -0.142-4.67%
Trading Apr 25 10:07 ET
494.76MMarket Cap-1386P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-39.10%95K
-10.00%-44K
-12.24%43K
-48.84%44K
-14.75%52K
-99.86%156K
-100.05%-40K
0.00%49K
95.45%86K
-99.84%61K
Operating revenue
-39.10%95K
-10.00%-44K
-12.24%43K
-48.84%44K
-14.75%52K
-99.86%156K
-100.05%-40K
0.00%49K
95.45%86K
-99.84%61K
Cost of revenue
Gross profit
Operating expense
-6.29%314.59M
-25.45%71.89M
-23.65%63.02M
5.06%80.56M
23.82%99.12M
14.07%335.69M
30.40%96.42M
6.20%82.54M
7.89%76.68M
11.89%80.05M
Selling and administrative expenses
-9.62%71.67M
-17.99%17.22M
-9.82%17.04M
-5.05%18.52M
-5.09%18.88M
7.02%79.31M
5.22%21M
-0.54%18.9M
3.87%19.51M
21.60%19.9M
-General and administrative expense
-9.62%71.67M
-17.99%17.22M
-9.82%17.04M
-5.05%18.52M
-5.09%18.88M
7.02%79.31M
5.22%21M
-0.54%18.9M
3.87%19.51M
21.60%19.9M
Research and development costs
-5.25%242.91M
-27.52%54.66M
-27.76%45.98M
8.51%62.04M
33.38%80.24M
16.45%256.39M
39.71%75.42M
8.38%63.64M
9.33%57.17M
9.01%60.16M
Operating profit
6.27%-314.49M
25.43%-71.93M
23.66%-62.98M
-5.12%-80.52M
-23.85%-99.07M
-86.21%-335.54M
-5,750.91%-96.46M
-6.20%-82.49M
-7.83%-76.59M
-140.93%-79.99M
Net non-operating interest income expense
300.94%18.31M
127.24%6.27M
519.26%6.21M
1,099.37%3.78M
318.50%2.06M
166.39%4.57M
1,382.26%2.76M
154.96%1M
-49.52%315K
-3.72%492K
Non-operating interest income
300.94%18.31M
127.24%6.27M
519.26%6.21M
1,099.37%3.78M
318.50%2.06M
166.39%4.57M
1,382.26%2.76M
154.96%1M
-49.52%315K
-3.72%492K
Other net income (expense)
-229.10%-31.08M
-164.35%-23.59M
-173.63%-4.55M
-183.71%-1.25M
-383.71%-1.69M
-164.32%-9.44M
-393.91%-8.93M
-82.73%-1.66M
380.98%1.49M
-7.69%-350K
Special income (charges)
---13.25M
----
----
----
----
----
----
----
----
----
-Less:Impairment of capital assets
--13.25M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-88.85%-17.84M
-15.94%-10.35M
-173.63%-4.55M
-183.71%-1.25M
-383.71%-1.69M
-164.32%-9.44M
-393.91%-8.93M
-82.73%-1.66M
380.98%1.49M
-7.69%-350K
Income before tax
3.86%-327.27M
13.03%-89.26M
26.26%-61.32M
-4.28%-77.99M
-23.61%-98.7M
-86.99%-340.41M
-119,436.05%-102.63M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
Income tax
Net income
3.86%-327.27M
13.03%-89.26M
26.26%-61.32M
-4.28%-77.99M
-23.61%-98.7M
-86.99%-340.41M
-119,436.05%-102.63M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
Net income continuous Operations
3.86%-327.27M
13.03%-89.26M
26.26%-61.32M
-4.28%-77.99M
-23.61%-98.7M
-86.99%-340.41M
-119,436.05%-102.63M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
Minority interest income
Net income attributable to the parent company
3.86%-327.27M
13.03%-89.26M
26.26%-61.32M
-4.28%-77.99M
-23.61%-98.7M
-86.99%-340.41M
-119,436.05%-102.63M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.86%-327.27M
13.03%-89.26M
26.26%-61.32M
-4.28%-77.99M
-23.61%-98.7M
-86.99%-340.41M
-119,436.05%-102.63M
-6.35%-83.15M
-5.43%-74.79M
-141.86%-79.85M
Basic earnings per share
12.18%-2.09
18.18%-0.54
36.21%-0.37
-1.92%-0.53
-21.43%-0.68
-77.61%-2.38
-22.22%-0.66
-1.75%-0.58
1.89%-0.52
-124.00%-0.56
Diluted earnings per share
12.18%-2.09
18.18%-0.54
36.21%-0.37
-1.92%-0.53
-21.43%-0.68
-77.61%-2.38
-22.22%-0.66
-1.75%-0.58
1.89%-0.52
-124.00%-0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -39.10%95K-10.00%-44K-12.24%43K-48.84%44K-14.75%52K-99.86%156K-100.05%-40K0.00%49K95.45%86K-99.84%61K
Operating revenue -39.10%95K-10.00%-44K-12.24%43K-48.84%44K-14.75%52K-99.86%156K-100.05%-40K0.00%49K95.45%86K-99.84%61K
Cost of revenue
Gross profit
Operating expense -6.29%314.59M-25.45%71.89M-23.65%63.02M5.06%80.56M23.82%99.12M14.07%335.69M30.40%96.42M6.20%82.54M7.89%76.68M11.89%80.05M
Selling and administrative expenses -9.62%71.67M-17.99%17.22M-9.82%17.04M-5.05%18.52M-5.09%18.88M7.02%79.31M5.22%21M-0.54%18.9M3.87%19.51M21.60%19.9M
-General and administrative expense -9.62%71.67M-17.99%17.22M-9.82%17.04M-5.05%18.52M-5.09%18.88M7.02%79.31M5.22%21M-0.54%18.9M3.87%19.51M21.60%19.9M
Research and development costs -5.25%242.91M-27.52%54.66M-27.76%45.98M8.51%62.04M33.38%80.24M16.45%256.39M39.71%75.42M8.38%63.64M9.33%57.17M9.01%60.16M
Operating profit 6.27%-314.49M25.43%-71.93M23.66%-62.98M-5.12%-80.52M-23.85%-99.07M-86.21%-335.54M-5,750.91%-96.46M-6.20%-82.49M-7.83%-76.59M-140.93%-79.99M
Net non-operating interest income expense 300.94%18.31M127.24%6.27M519.26%6.21M1,099.37%3.78M318.50%2.06M166.39%4.57M1,382.26%2.76M154.96%1M-49.52%315K-3.72%492K
Non-operating interest income 300.94%18.31M127.24%6.27M519.26%6.21M1,099.37%3.78M318.50%2.06M166.39%4.57M1,382.26%2.76M154.96%1M-49.52%315K-3.72%492K
Other net income (expense) -229.10%-31.08M-164.35%-23.59M-173.63%-4.55M-183.71%-1.25M-383.71%-1.69M-164.32%-9.44M-393.91%-8.93M-82.73%-1.66M380.98%1.49M-7.69%-350K
Special income (charges) ---13.25M------------------------------------
-Less:Impairment of capital assets --13.25M------------------------------------
Other non- operating income (expenses) -88.85%-17.84M-15.94%-10.35M-173.63%-4.55M-183.71%-1.25M-383.71%-1.69M-164.32%-9.44M-393.91%-8.93M-82.73%-1.66M380.98%1.49M-7.69%-350K
Income before tax 3.86%-327.27M13.03%-89.26M26.26%-61.32M-4.28%-77.99M-23.61%-98.7M-86.99%-340.41M-119,436.05%-102.63M-6.35%-83.15M-5.43%-74.79M-141.86%-79.85M
Income tax
Net income 3.86%-327.27M13.03%-89.26M26.26%-61.32M-4.28%-77.99M-23.61%-98.7M-86.99%-340.41M-119,436.05%-102.63M-6.35%-83.15M-5.43%-74.79M-141.86%-79.85M
Net income continuous Operations 3.86%-327.27M13.03%-89.26M26.26%-61.32M-4.28%-77.99M-23.61%-98.7M-86.99%-340.41M-119,436.05%-102.63M-6.35%-83.15M-5.43%-74.79M-141.86%-79.85M
Minority interest income
Net income attributable to the parent company 3.86%-327.27M13.03%-89.26M26.26%-61.32M-4.28%-77.99M-23.61%-98.7M-86.99%-340.41M-119,436.05%-102.63M-6.35%-83.15M-5.43%-74.79M-141.86%-79.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.86%-327.27M13.03%-89.26M26.26%-61.32M-4.28%-77.99M-23.61%-98.7M-86.99%-340.41M-119,436.05%-102.63M-6.35%-83.15M-5.43%-74.79M-141.86%-79.85M
Basic earnings per share 12.18%-2.0918.18%-0.5436.21%-0.37-1.92%-0.53-21.43%-0.68-77.61%-2.38-22.22%-0.66-1.75%-0.581.89%-0.52-124.00%-0.56
Diluted earnings per share 12.18%-2.0918.18%-0.5436.21%-0.37-1.92%-0.53-21.43%-0.68-77.61%-2.38-22.22%-0.66-1.75%-0.581.89%-0.52-124.00%-0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg